MECHANISM OF ACTION OF CLOFIBRATE

This publication has 15 references indexed in Scilit:

• Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters
  Atherosclerosis, 1980
• The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate
  Atherosclerosis, 1980
• Effects of -chlorophenoxyisobutyric acid (CPIB) on the human liver
  Atherosclerosis, 1980
• Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
  Nature, 1980
• On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemia in type IV and type V hyperlipoproteinaemias
  Atherosclerosis, 1977
• Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia
  Metabolism, 1977
• Changes produced by clofibrate in hepatocytes of rats with sucrose-induced hyperlipidemia
  Experimental and Molecular Pathology, 1976
• Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.
  Journal of Clinical Investigation, 1975
• Mechanism of the Hypolipemic Effect of Clofibrate in Postabsorptive Man
  Journal of Clinical Investigation, 1973
• Red-Cell Antibodies in Acquired Hemolytic Anemia with Negative Antiglobulin Serum Tests
  New England Journal of Medicine, 1971